Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP925284.RADyh-uZ3EmWTgsgs1JBSM4O3MEWKFPnCBj47pTNAdIVI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP925284.RADyh-uZ3EmWTgsgs1JBSM4O3MEWKFPnCBj47pTNAdIVI130_assertion type Assertion NP925284.RADyh-uZ3EmWTgsgs1JBSM4O3MEWKFPnCBj47pTNAdIVI130_head.
- NP925284.RADyh-uZ3EmWTgsgs1JBSM4O3MEWKFPnCBj47pTNAdIVI130_assertion description "[While observed no correlation between ephrin ligand expression and clinical outcome in microarray datasets, ephrin-A1 and EphA2 protein co-expression was significantly associated with recurrence in Stage I prognostic breast cancer TMAs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP925284.RADyh-uZ3EmWTgsgs1JBSM4O3MEWKFPnCBj47pTNAdIVI130_provenance.
- NP925284.RADyh-uZ3EmWTgsgs1JBSM4O3MEWKFPnCBj47pTNAdIVI130_assertion evidence source_evidence_literature NP925284.RADyh-uZ3EmWTgsgs1JBSM4O3MEWKFPnCBj47pTNAdIVI130_provenance.
- NP925284.RADyh-uZ3EmWTgsgs1JBSM4O3MEWKFPnCBj47pTNAdIVI130_assertion SIO_000772 21935409 NP925284.RADyh-uZ3EmWTgsgs1JBSM4O3MEWKFPnCBj47pTNAdIVI130_provenance.
- NP925284.RADyh-uZ3EmWTgsgs1JBSM4O3MEWKFPnCBj47pTNAdIVI130_assertion wasDerivedFrom befree-2016 NP925284.RADyh-uZ3EmWTgsgs1JBSM4O3MEWKFPnCBj47pTNAdIVI130_provenance.
- NP925284.RADyh-uZ3EmWTgsgs1JBSM4O3MEWKFPnCBj47pTNAdIVI130_assertion wasGeneratedBy ECO_0000203 NP925284.RADyh-uZ3EmWTgsgs1JBSM4O3MEWKFPnCBj47pTNAdIVI130_provenance.